Sulfagenix sulfagenix.com


Sulfagenix, Inc., and its wholly owned subsidiary, Sulfagenix Australia Pty. Ltd, are built on decades of research on modifying existing molecules to improve safety, bioavailability and efficacy for new uses. SG1002, the Company's lead molecule, is a precursor to a natural-occurring molecule, hydrogen sulfide, for which deficits have been shown to exist in a number of serious diseases, including cardiovascular disease, type II diabetes, cancer, hypertension, Alzheimer's Disease, asthma, & wound ...Show all

Sulfagenix, Inc., and its wholly owned subsidiary, Sulfagenix Australia Pty. Ltd, are built on decades of research on modifying existing molecules to improve safety, bioavailability and efficacy for new uses. SG1002, the Company's lead molecule, is a...Show all

Company (Alive / Active)

Phone: 512-499-3646

Fax:

7515 Cedar Rd

Chesterland, 44026
Ohio, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sulfagenix $2.7M Dec 27, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sulfagenix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods and compositions for treating nitric oxide deficiency disorders and related conditions Jun 02, 2015 Application